The dexamethasone suppression test in patients with mood disorders

Journal of Clinical Psychiatry

Volumn 57, Issue 10, 1996, Pages 470-484

  Rush, A John ^a   Giles, Donna E ^b   Schiesser, Michael A ^c   Orsulak, Paul J ^d   Parker Jr , C Richard ^e   Weissenburger, Jan E ^f   Crowley, George T ^d   Khatami, Manoochehr ^a   Vasavada, Nishendu ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c Dallas Surgical Associates   (United States)

^d VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f Clinical Microbiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; AGED; ARTICLE; BIPOLAR DEPRESSION; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYMPTOM;

EID: 0029830422     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v57n1006     Document Type: Article

References (158)

1. Sachar EJ, Hellman L, Fukushima DK. Cortisol production in depressive illness: a clinical and biochemical clarification. Arch Gen Psychiatry 1970;23:289-298
2. Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression, I: limbic system-adrenocortical dysfunction. Arch Gen Psychiatry 1976;33:1039-1044
3. Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression, II: discrimination of depressed from nondepressed patients. Arch Gen Psychiatry 1976;33:1051-1057
4. Ettigi P, Brown GM. Psychoneuroendocrinology of affective disorders: an overview. Am J Psychiatry 1977;134:493-501
5. Rubin RT. Psychoendocrinology of major depression. Eur Arch Psychiatry Neurol Sci 1989;238:259-267
6. Carroll BJ, Feinberg M, Greden JF, et al. A specific laboratory test for the diagnosis of melancholia: standardization, validation and clinical utility. Arch Gen Psychiatry 1981;38:15-22
7. Carroll BJ. The dexamethasone suppression test for melancholia. Br J Psychiatry 1982;140:292-304
8. American Psychiatric Association Task Force on Laboratory Tests in Psychiatry. The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry 1987;144:1253-1262
9. Nuller JL, Ostroumova MN. Resistance to inhibiting effect of dexamethasone in patients with endogenous depression. Acta Psychiatr Scand 1980; 61:169-177
10. Coppen A, Abou-Saleh M, Milln P, et al. Dexamethasone suppression test in depression and other psychiatric illness. Br J Psychiatry 1983;142: 498-504
11. Dam H, Mellerup ET, Rafaelson OJ. The dexamethasone suppression test in depression. J Affect Disord 1985;8:95-103
12. Rush AJ, Giles DE, Roffwarg HP, et al. Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders. Biol Psychiatry 1982;17:327-341
13. Peselow ED, Goldring N, Fieve RR, et al. The dexamethasone suppression test in depressed outpatients and normal control subjects. Am J Psychiatry 1983;140:245-247
14. Shulman R, Diewold P. A two-dose dexamethasone suppression test in patients with psychiatric illness. Can Psychiatr Assoc J 1977;22:417-422
15. Holsboer F, Bender W, Benkert O, et al. Diagnostic value of dexamethasone suppression test in depression [letter]. Lancet 1980;2:706
16. Stokes PE, Stoll PM, Koslow SH, et al. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups: a multicenter study. Arch Gen Psychiatry 1984;41:257-267
17. Kocsis JH, Brockner N, Butler T, et al. Dexamethasone suppression in major depression. Biol Psychiatry 1984;19:1255-1259
18. Greden JF. Biological markers of melancholia and reclassification of depressive disorders. Encephale 1982;8:193-202
19. Kupfer DJ, Rush AJ. Recommendations for scientific reports on depression [editorial]. Am J Psychiatry 1983;40:1327-1328
20. Kraemer HC. The methodological and statistical evaluation of medical tests: the dexamethasone suppression test in psychiatry. Psychoneuroendocrinology 1987;12:411-427
21. Mossman D, Somoza E. Maximizing diagnostic information from the dexamethasone suppression lest. Arch Gen Psychiatry 1989;46:653-660
22. Winokur G, Behar D, Van Valkenberg C, et al. Is familial definition of depression both feasible and valid? J Nerv Ment Dis 1978;166:764-768
23. Carroll BJ, Greden JF, Feinberg M, et al. Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression. Psychiatry Res 1980; 2:251-258
24. Carroll BJ, Greden JF, Feinberg M, et al. Neuroendocrine evaluation of depression in borderline patients. Psychiatr Clin North Am 1981;4: 89-99
25. Schlesser MA, Winokur G, Sherman BM. Genetic subtypes of unipolar primary depressive illness distinguished by hypothalamic-pituitary-adrenal axis activity. Lancet 1979;1:739-741
26. Schlesser MA, Winokur G, Sherman BM. Hypothalamic-pituitary-adrenal axis activity in depressive illness: its relationship to classification. Arch Gen Psychiatry 1980;37:737-743
27. Agren H, Wilde L. Patterns of depression reflected in pituitary-thyroid and pituitary-adrenal endocrine changes. Psychoneuroendocrinology 1982;7: 309-327
28. Coryell W, Gaffney G, Burkhardt PE. DSM-III melancholia and the primary-secondary distinction: a comparison of concurrent validity by means of the dexamethasone suppression test. Am J Psychiatry 1982;139: 120-122
29. Zimmerman M, Coryell WH, Pfohl B, et al. Four definitions of endogenous depression and the dexamethasone suppression test. J Affect Disord 1985;8:37-45
30. Targum SD, Byrnes SM, Sullivan AC. Subtypes of unipolar depression distinguished by the dexamethasone suppression test. J Affect Disord 1982;4:21-27
31. Kasper S, Beckmann H. Dexamethasone suppression test in a pluri-diagnostic approach: its relationship to psychopathological and clinical variables. Acta Psychiatr Scand 1983;68:31-37
32. Mendlewicz J, Charles GA, Franckson JM. The dexamethasone suppression test in affective disorder relationship to clinical and genetic subgroups. Br J Psychiatry 1982;141:464-470
33. Asnis GM, Halbreich U, Nathan RS, et al. The dexamethasone suppression test in depressive illness: clinical correlates. Psychoneuroendocrinology 1982;7:295-301
34. Amsterdam JD, Winokur A, Caroff SN, et al. The dexamethasone suppression test in outpatients with primary affective disorders and healthy control subjects. Am J Psychiatry 1982;199:287-291
35. Rudorfer MV, Hwu HG, Clayton PJ. Dexamethasone suppression test in primary depression: significance of family history and psychosis. Biol Psychiatry 1982;17:41-48
36. Brown WA, Shuey I. Response to dexamethasone and subtype of depression. Arch Gen Psychiatry 1980;37:747-751
37. Winokur G, Black DW, Nasrallah A. DST nonsuppressor status: relationship to specific aspects of the depressive syndrome. Biol Psychiatry 1987;22:360-368
38. Giles DE, Schlesser MA, Rush AJ, et al. Polysomnographic findings and dexamethasone nonsuppression in unipolar depression: a replication and extension. Biol Psychiatry 1987;22:872-882
39. Arana GW, Baldessarini RJ, Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch Gen Psychiatry 1985; 42:1193-1204
40. Cames M, Smith JC, Kalin NH, et al. The dexamethasone suppression test in demented outpatients with and without depression. Psychiatry Res 1983;9:337-344
41. Rothschild AJ, Schatzberg AF, Rosenbaum AH, et al. The dexamethasone suppression test as a discriminator among subtypes of psychotic patients. Br J Psychiatry 1982;141:471-474
42. Schatzberg AF, Rothschild AJ, Stahl JB, et al. The dexamethasone suppression test: identification of subtypes of depression. Am J Psychiatry 1983;140:88-91
43. Raskind M, Peskind E, Rivard MF, et al. Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia. Am J Psychiatry 1982;139:1468-1471
44. Spar JE, Gerner R. Does the dexamethasone suppression test distinguish dementia from depression? Am J Psychiatry 1982;139:238-240
45. Balidin J, Gottfries CG, Karlsson I, et al. Dexamethasone suppression test and serum prolactin in dementia disorders. Br J Psychiatry 1983;143:277-281
46. Gerner RH, Gwirtsmann HE. Abnormalities of dexamethasone suppression test and urinary MHPG in anorexia nervosa. Am J Psychiatry 1981; 138:650-653
47. Doerr P, Fichter M, Pirke KM, et al. Relationship between weight gain and hypothalamic pituitary adrenal function in patients with anorexia nervosa. Journal of Steroid Biochemistry 1980;13:529-537
48. Oxenkrug GF. Dexamethasone test in alcoholics [letter]. Lancet 1978;2:795
49. Swartz CM, Dunner FJ. Dexamethasone suppression testing of alcoholics. Arch Gen Psychiatry 1982;39:1309-1312
50. Castro P, LeMaire M, Toscano-Aguilar M. Abnormal DST results in patients with chronic schizophrenia [letter]. Am J Psychiatry 1983;140:1261
51. Dewan MJ, Pandurangi AK, Boucher ML, et al. Abnormal dexamethasone suppression test results in chronic schizophrenic patients. Am J Psychiatry 1982;139:1501-1503
52. Arana GW, Barreira PJ, Cohen BM, et al. The dexamethasone suppression test in psychotic disorders. Am J Psychiatry 1983;140:1521-1523
53. Coccara EF, Prudic J, Rothpearl A, et al. Clinical utilization of the dexamethasone suppression test. J Clin Psychiatry 1984;45:382-384
54. Insel TR, Kaiin NH, Guttmacher LB, et al. The dexamethasone suppression test in patients with primary obsessive-compulsive disorder. Psychiatry Res 1982;6:153-160
55. Steiner M, Links PS, Korzekwa M. Biological markers in borderline personality disorder. Can J Psychiatry 1988;33:350-354
56. Greden JF, Kronfol Z, Gardwen R, et al. Neuroendocrine evaluation of schizoaffectives with the dexamethasone suppression test. Presented at the Third World Congress of Biological Psychiatry; July 1981; Stockholm, Sweden
57. Finklestein S, Benowitz LI, Baldessarini RJ, et al. Mood, vegetative disturbance, and dexamethasone suppression test after stroke. Ann Neurol 1982; 12:463-468
58. Lipsey JR, Robinson RG, Pearlson GC, et al. The dexamethasone suppression test and mood following stroke. Am J Psychiatry 1985;142: 318-323
59. Harney JH, Fulton C, Ross ED, et al. Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarctions. J Clin Psychiatry 1993;54:343-348
60. Carroll BJ. Biologic markers and treatment response. J Clin Psychiatry 1983;44(8, sec 2):30-40
61. Carroll BJ. Dexamethasone suppression test: a review of contemporary confusion. J Clin Psychiatry 1985;46(2, sec 2):13-24
62. Korzekwa M, Steiner M, Links P, et al. The dexamethasone suppression test in borderlines: is it useful? Can J Psychiatry 1991;36:26-28
63. Olivera AA, Fero D, Scibilia J. Dexamethasone suppression test in psychiatric patients with psychoactive substance dependence. Am J Drug Alcohol Abuse 1991;17:295-305
64. Khan A, Ciraulo DA, Nelson WH, et al. Dexamethasone suppression test in recently detoxified alcoholics: clinical implications. J Clin Psychopharmacol 1984;4:94-97
65. Sheehan DV, Claycomb JB, Surman OS, et al. Panic attacks and the dexamethasone suppression test. Am J Psychiatry 1983;140:1063-1064
66. Curtis GC, Cameron OG, Nesse RM. The dexamethasone suppression test in panic disorder and agoraphobia. Am J Psychiatry 1982;139:1043-1045
67. Gold MS, Pottash ALC, Extein I, et al. Diagnosis of depression in the 1980's. JAMA 1981;245:1562-1564
68. Charles GA, Lefevre A, Mirel J, et al. Suppression of cortisol following dexamethasone in demented patients. Psychiatry Res 1986;17:173-182
69. Davis KL, Davis BM, Mathe AA, et al. Age and the dexamethasone suppression test. Am J Psychiatry 1984;141:872-874
70. Nelson WH, Khan A, Orr WW Jr, et al. The dexamethasone suppression test: interaction of diagnosis, sex and age in psychiatric inpatients. Biol Psychiatry 1984;9:1293-1304
71. Lewis DA, Pfohl B, Schlechte J, et al. Influence of age on the cortisol response to dexamethasone. Psychiatry Res 1984;13:213-220
72. Halbreich U, Asnis GM, Zumoff B, et al. Effect of age and sex on cortisol secretion in depressives and normals. Psychiatry Res 1984;13:221-229
73. Baumgartner A, Haack D, Vecsei P. Serial dexamethasone suppression tests in psychiatric illness, part III: the influence of intervening variables. Psychiatry Res 1986;18:45-64
74. Whiteford HA, Peabody CA, Thiemann S, et al. The effect of age on baseline and post-dexamethasone cortisol levels in depressive disorder. Biol Psychiatry 1987;22:1029-1032
75. Weiner MF. Age and cortisol suppression by dexamethasone in normal subjects. J Psychiatr Res 1989;23:163-168
76. Tourigny-Rivard MF, Raskind M, Rivard D. The dexamethasone suppression test in an elderly population. Biol Psychiatry 1981;16:1177-1184
77. Aguilar MT, Lemaire M, Castro P, et al. A study of the diagnostic value of the dexamethasone suppression test in endogenous depression. J Affect Disord 1984;6:33-42
78. Greden JF, Flegel P, Haskett R, et al. Age effects in serial hypothalamic-pituitary-adrenal monitoring. Psychoneuroendocrinology 1986;11:195-204
79. Ferrier IN, Pascual J, Charlton BG, et al. Cortisol, ACTH, and dexamethasone concentrations in a psychogeriatric population. Biol Psychiatry 1988;23:252-260
80. Schweitzer I, Tucknell VM, Maguire KP, et al. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers. Psychoneuroendocrinology 1991;16:375-382
81. Maes M, Vandewoude M, Schotte C, et al. Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. Neuropsychobiology 1989;22:26-32
82. Maes M, Schotte C, D'Hondt P, et al. Biological heterogeneity of melancholia: results of pattern recognition methods. J Psychiatr Res 1991;25: 95-108
83. von Bardeleben U, Holsboer F. Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone. Biol Psychiatry 1991;29:1042-1050
84. Coccaro EF, Prudic J, Rothpearl A, et al. Effect of hospital admission on DST results. Am J Psychiatry 1984;141:982-985
85. Mellsop GW, Hutton JD, Delahunt JW. Dexamethasone suppression test as a simple measure of stress? BMJ 1985;290:1804-1806
86. Giles DE, Rush AJ. Relationship of dysfunctional attitudes and dexamethasone response in endogenous and nonendogenous depression. Biol Psychiatry 1982;17:1303-1314
87. Zimmerman M, Coryell W, Pfohl B. The validity of the dexamethasone suppression test as a marker for endogenous depression. Arch Gen Psychiatry 1986;43:347-355
88. Hwu HG, Lin HN. Serial dexamethasone suppression test in psychiatric inpatients. Biol Psychiatry 1990;27:609-616
89. Blouin J, Spindler E, Perez E, et al. The role of stress in interpreting the dexamethasone suppression test. Can J Psychiatry 1992;37:724-727
90. Haskett RF, Zis AP, Albala AA, et al. Comparison of early and delayed inpatient dexamethasone suppression tests. Psychiatry Res 1989;27: 161-171
91. Berger M, Pirke KM, Doerr P, et al. Influence of weight loss on the dexamethasone suppression test [letter]. Arch Gen Psychiatry 1983;40: 585-586
92. Edelstein CK, Roy-Byrne P, Fawzy FI, et al. Effects of weight loss on the dexamethasone suppression test. Am J Psychiatry 1983;140:338-341
93. Kline MD, Beeber AR. Weight loss and the dexamethasone suppression test. Arch Gen Psychiatry 1983;40:1034-1035
94. Targum SD. Reported weight change and the dexamethasone suppression test. Psychiatry Res 1983;9:173-174
95. Maes M, Maes L, Suy E. Symptom profiles of biological markers in depression: a multivariate study. Psychoneuroendocrinology 1990;15: 29-37
96. Feinberg M, Carroll BJ. Biological "markers" for endogenous depression: effect of age, severity of illness, weight loss, and polarity. Arch Gen Psychiatry 1984;41:1080-1085
97. Zimmerman M, Pfohl B, Coryell WH. Appetite and weight change and the dexamethasone suppression test. Biol Psychiatry 1984;19: 923-928
98. Gwirtsman HE, Roy-Byrne P, Gitlin MJ, et al. Reported weight loss and dexamethasone nonsuppression in depressed patients: a negative study. J Affect Disord 1985;9:193-196
99. Keimer GI, Brown WA, Quails B, et al. Results of the dexamethasone suppression test in psychiatric patients with and without weight loss. Am J Psychiatry 1985;142:246-248
100. Krishan KRR, France RD, Snipes MT, et al. Weight change and the dexamethasone suppression test. Biol Psychiatry 1985;20:1015-1018
101. Pfohl B, Coryell W, Stangl D, et al. Body weight and reported versus measured weight loss as confounders of the dexamethasone suppression test. Biol Psychiatry 1986;21:931-938
102. Evans DL, Burnett GB, Nemeroff CB. The dexamethasone suppression test in the clinical setting. Am J Psychiatry 1983;140:586-589
103. Maes M, DeRuyter M, Suy E. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings. Psychoneuroendocrinology 1989;14:231-240
104. Brown WA, Johnston R, Mayfield D. The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms, and response to treatment. Am J Psychiatry 1979;136:543-547
105. Stokes PE, Stoll PM, Mattson MR, et al. Diagnosis and psychopathology in psychiatric patients resistant to dexamethasone. In: Sachar EJ, ed. Hormones, Behavior and Psychopathology. New York, NY: Raven Press; 1976
106. Hwu HG, Chen TS, Yang YY. The clinical diagnostic value of dexamethasone suppression test in depressive illness. Ann Acad Med Singapore 1985;14:104-109
107. Carroll BJ, Martin FIR, Davies BM. Resistance to suppression by dexantethasone of plasma 11-OHCS levels in severe depressive illness. BMJ 1968;3:285-287
108. Georgotas A, Stokes PE, Hapworth WE, et al. The relationship of the dexamethasone suppression test to subtypes of depression and to symptom severity in the elderly. J Affect Disord 1986;10:51-57
109. Kumar A, Alcser K, Grunhaus L, et al. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia. Biol Psychiatry 1986;21:436-444
110. Meador-Woodruff JH, Haskett RF, Grunhaus L, et al. Postdexamethasone plasma cortisol and β-endorphin levels in depression: relationship to severity of illness. Biol Psychiatry 1987;22:1137-1150
111. Drateu L, Calil HM. The dexamethasone suppression test: its relationship to diagnosis, severity of depression and response to treatment. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:99-117
112. Carroll BJ, Davies BM. Clinical associations of 11-hydroxycorticosteroid suppression and nonsuppression in severe depressive illness. BMJ 1970;1:789-791
113. Targum SD, Rosen L, Capodanno AE. The dexamethasone suppression test in suicidal patients with unipolar depression. Am J Psychiatry 1983;140:877-879
114. Steiner M, Brown GM, Goldman S. Nocturnal melatonin and cortisol secretion in newly admitted psychiatric inpatients: implications for affective disorders. Eur Arch Psychiatry Clin Neurosci 1990;240:21-27
115. Meador-Woodruff JH, Greden JF, Grunhaus L, et al. Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors. Acta Psychiatr Scand 1990;81:364-371
116. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
117. Staner L, Maes M, Bouillon E, et al. Biological correlates of the Newcastle scale in depressive illness: a multivariate approach. Acta Psychiatr Scand 1992;85:345-350
118. Klein HE, Bender W, Mayr H, et al. The DST and its relationships to psychiatric diagnosis, symptoms, and treatment outcome. Br J Psychiatry 1984;145:591-599
119. Thompson LM, Rubin RT, McCracken JT. Neuroendocrine aspects of primary endogenous depression, XII: receiver operator characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls. Psychoneuroendocrinology 1992;17:507-515
120. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978;35:773-782
121. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980
122. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978;35: 837-844
123. Andreasen NC, Endicott, J, Spitzer RL, et al. The family history method using diagnostic criteria. Arch Gen Psychiatry 1977;34:1229-1235
124. Rush AJ, Schlesser MA, Roffwarg HP, et al. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings. J Clin Psychiatry 1983;44:23-29
125. Orsulak PJ, Gershon ES. Therapeutic monitoring of tricyclic antidepressants: quality control considerations. Ther Drug Monit 1980;2:233-242
126. Orsulak PJ, Gershon ES. Clinical laboratory quality control: application to analysis of tricyclic antidepressants. In: Usdin E, ed. Clinical Pharmacology in Psychiatry. New York, NY: Elsevier; 1981:43-57
127. Dixon WJ, Brown MB, Engelman L, et al. BMDP Statistical Software. Berkeley, Calif: University of California Press; 1983
128. SAS Institute Inc. SAS/STAT User's Guide, Version 6, vol 1, 2. 4th ed. Cary, NC: SAS Institute Inc; 1990
129. Gaddum JH. Log-normal distributions. Nature 1945;156:463-466
130. Heath DF. Normal or log-normal: appropriate distribution. Nature 1967; 213:1159-1160
131. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death, 8th revision (ICD-8). Geneva, Switzerland: WHO; 1968
132. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death, 9th revision (ICD-9). Geneva, Switzerland: WHO; 1977
133. Gurney C. Diagnostic scales for affective disorders, In: Proceedings of the 5th World Congress of Psychiatry; 1971; Mexico City, Mexico. Page 330
134. Bech P, Gram LR, Reisby N, et al. The WHO depression scale: relationship to the Newcastle scales. Ada Psychiatr Scand 1980;62:140-155
135. Giles DE, Biggs MM, Roffwarg HP, et al. Secondary depression: a comparison among subtypes. J Affect Disord 1987;12:251-258
136. Fleming JE, Exlein I, Sternbach HA, et al. The thyrotropin-releasing hormone and dexamethasone suppression tests in the familial classification of depression. Psychiatry Res 1983;9:53-58
137. Davidson J, Lipper S, Zung WWK, et al. Validation of four definitions of melancholia by the dexamethasone suppression test. Am J Psychiatry 1984;141:1220-1223
138. Calloway SP, Dolan RJ, Fonagy P, et al. Endocrine changes and clinical profiles in depression, I: the dexamethasone suppression test. Psychol Med 1984;14:749-758
139. Rabkin JG, Quitkin FM, Stewart JR, et al. The dexamethasone suppression test with mildly to moderately depressed outpatients. Am J Psychiatry 1983;140:926-927
140. Prabhu V, el-Guebaly N. Cortisol secretion and DST in affective disorders: methodological concerns. Can J Psychiatry 1983;28:602-611
141. Cook N, Harris B, Walker R, et al. Clinical utility of the dexamethasone suppression test assessed by plasma and salivary cortisol determinations. Psychiatry Res 1986;18:143-150
142. Brown RP, Stoll PM, Stokes PE, et al. Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia and other illness variables. Psychiatry Res 1988;23:167-178
143. Ames D, Burrows G, Davies B, et al. A study of the dexamethasone suppression test in hospitalized depressed patients. Br J Psychiatry 1984; 144:311-313
144. Extein I, Pottash ALC, Gold MS. Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression. Psychoneuroendocrinology 1985;10:281-288
145. Gitlin MJ, Gwirtsman H, Fairbanks L, et al. Dexamethasone suppression test and treatment response. J Clin Psychiatry 1984;45:387-389
146. Peselow ED, Baxter N, Fieve RR, et al. The dexamethasone suppression test as a monitor of clinical recovery. Am J Psychiatry 1987;144:30-35
147. Rush AJ, Cain JW, Raese J, et al. Neurobiological bases for psychiatric disorders. In: Rosenberg RN, ed. Comprehensive Neurology. New York, NY: Raven Press; 1991:555-603
148. Rush AJ, Weissenburger JE. Melancholic symptom features and DSM-IV. Am J Psychiatry 1994;151:489-498
149. Depression Guideline Panel. Clinical Practice Guideline Number 5. Depression in Primary Care, vol 2: Treatment of Major Depression. Rockville, Md: US Dept Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 93-0551;1993
150. Charles GA, Vanderwalle J, Meunier JC, et al. Plasma and urinary cortisol levels after dexamethasone in affective disorders. J Affect Disord 1981;3:397-406
151. Papakostas Y, Fink M, Lee J, et al. Neuroendocrine measures in psychiatric patients: course and outcome with ECT. Psychiatry Res 1981;4: 55-64
152. Berger M, Doerr P, Lund R, et al. Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype? Biol Psychiatry 1982;17: 1217-1242
153. Mendlewicz J, Kerkhofs M, Hoffman G, et al. Dexamethasone suppression test and REM sleep in patients with major depressive disorder. Br J Psychiatry 1984;145:383-388
154. Johnson GF, Hunt G, Kerr K, et al. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients. Psychiatry Res 1984;13:305-313
155. Rubin RT, Poland RE, Lesser IM, et al. Neuroendocrine aspects of primary endogenous depression, III: cortisol secretion in relation to diagnosis and symptom patterns. Psychol Med 1987;17:609-619
156. Berger M, Pirke KM, Doerr P, et al. The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. Br J Psychiatry 1984;145:372-382
157. McIntyre IM, Norman TR, Burrows GD, et al. [letter]. BMJ 1981;283: 1609-1610
158. Holden NL. Depression and the Newcastle scale: their relationship to the dexamethasone suppression test. Br J Psychiatry 1983;142:505-507